Authoritative Response: False Positives Do Not Indicate Reduced Sensitivity of Nucleic Acid Testing Against Omicron; Routine Testing Must Not Be One-Size-Fits-All
This document provides official clarifications addressing public concerns about nucleic acid testing sensitivity to the Omicron variant and emphasizes that routine COVID-19 testing policies should be implemented flexibly without a one-size-fits-all approach.